Stem Cell Transplant: New T Cell Therapy
We are studying a new treatment using special T cells to help prevent complications in patients receiving stem cell transplants from siblings. The goal is to see if this approach can safely reduce the need for other medications.
6-12 months16-20 visitsSafety phase (I)Efficacy phase (II)No PlaceboInvestigational MedicinesInjectionHematologyInfectious DiseasesInternal Medicine
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you between 16 and 75 years old?
- Do you have any serious infections that are not responding to treatment?
- Are you currently taking cyclosporine (like Neoral or Sandimmune) for your health?
- Are you pregnant or breastfeeding?
- Do you have any active viral infections like HIV, Hepatitis B, or Hepatitis C?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Epigenome HLA-G+ T-regulatory cells (iG-Tregs)
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Geniko Nosokomeio Thessalonikis George Papanikolaou
Gene and Cellular Therapy Unit, Hematopoietic Cell Transplantation Unit, Hematology Clinic
Asvestochóri, Greece
General University Hospital Of Patras
Bone Marrow Transplantation Unit
Pátra, Greece
Sponsor: University Of Patras
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.